Aspirin thromboprophylaxis of asymptomatic antiphospholipid-positive subjects

Internal and Emergency Medicine

Volumn 4, Issue 1, 2009, Pages 63-64

  Galli, Monica ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PHOSPHOLIPID ANTIBODY;

ARTICLE; BLOOD; HUMAN; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ASPIRIN; HUMANS; THROMBOSIS;

EID: 59449109847     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-008-0203-6     Document Type: Article

References (15)

1. M Gerosa G Chighizola PG Meroni 2008 Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases) Intern Emerg Med 3 201 203
2. G Finazzi 2008 Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No Intern Emerg Med 3 197 200
3. JA Giron-Gonzalez E Garcia del Rio C Rodriguez J Rodriguez-Martorell A Serrano 2004 Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals J Rheumatol 31 1560 1567
4. M Galli G Finazzi F Duca F Norbis M Moia 2000 The G1691A mutation of factor V, but not the G20210A mutatiin of factor II or the C677T mutation of methylenethetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants Br J Haematol 108 865 870
5. RJ Glynn PM Ridker SZ Goldhaber JE Buring 2007 Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial Ann Intern Med 147 525 533
6. D Mari PM Mannucci R Coppola B Bottasso KA Bauer RD Rosenberg 1995 Hypercoagulability in centenarians: the paradox of successful aging Blood 85 3144 3149
7. M Galli D Luciani G Bertolini T Barbui 2003 Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood 101 1827 1832
8. M Galli D Luciani G Bertolini T Barbui 2003 Antiβ2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome Blood 102 2717 2723
9. DA Horbach E van Oort RHWM Derksen PG de Groot 1998 The contribution of anti-prothrombin antibodies to the lupus anticoagulant activity-discrimination between functional and non-function anti-prothrombin antibodies J Thromb Haemost 79 790 795
10. MJ Simmelink RHWM Derksen J Arnout PG de Groot 2003 A simple method to discriminate between β2-glycoprotein I and prothrombin-dependent lupus anticoagulants J Thromb Haemost 1 740 747
11. V Pengo A Biasiolo C Pegoraro S Iliceto 2004 A two-step coagulation test to identify aβ2-glycoprotein I lupus anticoagulants J Thromb Haemost 2 702 707
12. HB De Laat RHWM Derksen RT Urbanus M Roest PG de Groot 2004 β2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome Blood 104 3598 3602
13. B De Laat RHWM Derksen RT Urbanus PG de Groot 2005 IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis Blood 105 1540 1545
14. P Rix J Stentoft NA Aunsholt M Dueholm KA Tilma M Høier-Madsen 1992 Lupus anticoagulant and anticardiolipin antibodies in an obstetric population Acta Obstet Gynecol Scand 71 605 609
15. JF Schved C Dupuy-Fons C Biron I Quére C Janbon 1994 A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier antiphospholipid (MAP) study Haemostasis 24 175 182